Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Amicus Therapeutics, Inc. (FOLD) had Weighted-Average Shares Outstanding (Diluted) of 304.38M for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
$528.29M |
|
$-56.11M |
|
$52.94M |
|
$475.35M |
|
$503.42M |
|
$24.88M |
|
$-53.63M |
|
$-28.76M |
|
$-28.76M |
|
$-56.11M |
|
$-56.11M |
|
$-56.11M |
|
$-56.11M |
|
$24.88M |
|
$35.69M |
|
304.38M |
|
Weighted-Average Shares Outstanding (Diluted) |
304.38M |
$-0.18 |
|
$-0.18 |
|
Balance Sheet Financials | |
$504.74M |
|
$29.38M |
|
$280.30M |
|
$785.03M |
|
$148.70M |
|
$390.11M |
|
$442.29M |
|
$590.99M |
|
$194.05M |
|
$-20.95M |
|
$194.04M |
|
299.04M |
|
Cash Flow Statement Financials | |
$-33.89M |
|
$-0.56M |
|
$5.12M |
|
$250.08M |
|
$216.72M |
|
$-33.36M |
|
$84.91M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
3.39 |
|
-- |
|
-- |
|
0.67 |
|
2.01 |
|
89.98% |
|
4.71% |
|
4.71% |
|
6.75% |
|
-5.44% |
|
-10.62% |
|
$-37.44M |
|
-- |
|
-- |
|
-- |
|
0.67 |
|
0.45 |
|
5.23 |
|
69.85 |
|
-28.91% |
|
267.81% |
|
-7.15% |
|
-9.60% |
|
$0.65 |
|
$-0.12 |
|
$-0.11 |